Preferences of patients with #malignant_melanoma to accept adjuvant therapy are based on treatment efficacy, side effects, and quality of life. Personalised approaches are essential for shared #decision-making. 👇🏽📄 pubmed.ncbi.nlm.nih.gov/39627632/ - ThreadSky

ivdp-hamburg.bsky.social • 43 days ago

Preferences of patients with #malignant_melanoma to accept adjuvant therapy are based on treatment efficacy, side effects, and quality of life. Personalised approaches are essential for shared #decision-making.
👇🏽📄
https://pubmed.ncbi.nlm.nih.gov/39627632/

Comments

Posting Rules

Comments

Posting Rules

Reply